The University of Warwick Library - WebBridge

NEAT-A: accelerated sequential epirubicin followed by higher dose 14 day CMF, using pegfilgrastim, is a feasible alternative for delivering dose dense E-CMF chemotherapy in early breast cancer
Bowden, S..  14th European Cancer Conference (ECCO 14).  v. Vol.5. no. No.4.   2007-09. p. 194 - 195... issn: 1359-6349 .   

Online access not found

Sorry - based on the information provided, WebBridge cannot offer appropriate links.